Reclassification of obstetric antiphospholipid syndrome under the 2023 ACR/EULAR criteria: risk of under-recognition in patients with non-criteria antibodies and clinical implications

作者
盛庭偉,Yuqi Tang,Zhengwei Tan,Ling Liu,戴巧定
出处
期刊:Frontiers in Medicine [Frontiers Media]
卷期号:13: 1929786-1929786
标识
DOI:10.3389/fmed.2026.1929786
摘要

Objective To characterize the clinical, serologic, and treatment features of patients with obstetric antiphospholipid syndrome (OAPS), determine the proportion meeting the laboratory domain of the 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) classification criteria, and examine patients identified through non-criteria antibodies. Methods We retrospectively reviewed consecutive women with a prior clinical diagnosis of OAPS at our center and assigned de-identified codes P1-P45. Of the 45 patients, 41 had sufficiently complete historical serologic documentation for laboratory-domain reclassification; P10, P17, P34 and P42 were retained in the descriptive cohort but treated as not assessable in the evaluable-case analysis. Two investigators independently scored each evaluable patient across the six clinical domains and two laboratory domains; classification required a cumulative score of ≥3 in both the clinical and laboratory domains. For patients with concomitant systemic lupus erythematosus (SLE), obstetric or hematologic manifestations attributable to SLE were excluded from APS scoring. Results A total of 45 patients were included, all female, with a mean age of 33.7 years (43 primary APS, 2 SLE-associated). Thirty-two patients (71.1%) had a history of pregnancy loss, and 20 had recurrent miscarriage. Anticardiolipin (aCL) IgG and IgM were positive in 9 and 14 patients, respectively; anti- β 2-glycoprotein I (anti- β 2GPI) IgG and IgM were positive in 2 and 16 patients, respectively; lupus anticoagulant (LAC) was positive in 2 patients. Fourteen patients (31.1%) carried non-criteria antibodies, including 7 with non-criteria antibodies only. Among the 41 patients with evaluable serologic data, 7/41 (17.1%) definitively met the ≥3-point laboratory threshold and 11/41 (26.8%) met it under the upper-bound assumptions. In the conservative sensitivity analysis, which counted P10, P17, P34 and P42 as below threshold, the corresponding estimates were 7/45 (15.6%) and 11/45 (24.4%). Patients with isolated IgM positivity, IgA-only antibodies, single-positive LAC, or non-criteria antibodies alone did not meet the threshold. An exploratory comparison found no statistically significant difference in documented standardized intervention between live-birth and further-loss cases [28/36 [77.8%] vs 6/9 [66.7%]; two-sided Fisher's exact p = 0.666]. Conclusion In this single-center retrospective series of 45 patients, many patients were identified through non-criteria antibodies or low-weight serologic profiles and therefore did not meet the 2023 laboratory-domain threshold. Because of the small sample, these findings are descriptive and hypothesis-generating and should not be generalized. Nevertheless, they support using the 2023 criteria primarily to define homogeneous research cohorts rather than as a stand-alone basis for diagnosis or treatment decisions. Whether the obstetric phenotype requires a separate classification approach remains to be determined.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
u308479完成签到,获得积分10
刚刚
1秒前
2秒前
u305068完成签到,获得积分10
2秒前
小于发布了新的文献求助10
3秒前
4秒前
victor完成签到,获得积分0
4秒前
4秒前
乐乐的应助被谦让的语儿采纳,获得10
5秒前
u989740完成签到,获得积分10
5秒前
5秒前
Sam发布了新的文献求助10
5秒前
康少发布了新的文献求助10
5秒前
6秒前
u149385完成签到,获得积分10
7秒前
Nole的应助被Lily采纳,获得10
7秒前
贾文浩发布了新的文献求助10
7秒前
7秒前
u557314完成签到,获得积分10
7秒前
8秒前
9秒前
Lucas的应助被无私的画笔采纳,获得10
9秒前
10秒前
H11103y发布了新的文献求助10
10秒前
大模型的应助被qin202569采纳,获得10
10秒前
nan发布了新的文献求助10
11秒前
Hik完成签到,获得积分20
11秒前
儒雅的焦发布了新的文献求助10
11秒前
u644628完成签到,获得积分10
12秒前
u936662完成签到,获得积分10
13秒前
13秒前
14秒前
经竺的应助被369ninja采纳,获得10
14秒前
15秒前
ys完成签到,获得积分10
15秒前
赘婿的应助被Wyf采纳,获得10
15秒前
lvyuan完成签到,获得积分10
16秒前
Ava的应助被科研白采纳,获得10
16秒前
17秒前
ad发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573479
关于积分的说明 21831986
捐赠科研通 7781752
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962